Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||
| Net Income | 55 | 927 |
| Depreciation Amortization | 1,208 | 967 |
| Income taxes - deferred | 182 | 28 |
| Accounts receivable | -404 | -727 |
| Other Working Capital | -2,395 | -700 |
| Other Operating Activity | 152 | 1,187 |
| Operating Cash Flow | $-1,202 | $1,682 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 300 | -300 |
| PPE Investments | -526 | -988 |
| Net Acquisitions | -1,379 | -500 |
| Purchase Sale Intangibles | N/A | -575 |
| Other Investing Activity | 223 | -1,119 |
| Investing Cash Flow | $-1,382 | $-2,907 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -779 | -763 |
| Common Stock Issued | 3,115 | 2,216 |
| Common Stock Repurchased | -561 | -84 |
| Other Financing Activity | 713 | -11 |
| Financing Cash Flow | $2,488 | $1,358 |
| Exchange Rate Effect | 189 | 32 |
| Beginning Cash Position | 724 | 559 |
| End Cash Position | 817 | 724 |
| Net Cash Flow | $93 | $165 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,202 | 1,682 |
| Capital Expenditure | -1,013 | -988 |
| Free Cash Flow | -2,215 | 694 |